24-hour Efficacy of AR-12286
NCT01330979
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class
Conditions
Open Angle Glaucoma
Ocular Hypertension
Interventions
DRUG:
AR-12286 0.5% Ophthalmic Solution
Sponsor
Aerie Pharmaceuticals